share_log

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.

Benzinga ·  Aug 4, 2022 14:56
Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results and reaffirmed guidance.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment